Manzano A, Hofmarcher T
Endometrial Cancer – Improving Care and Driving Policy Change
Some 90% of all cancers originating in the body of the uterus (corpus uteri) are classified as endometrial cancer. It is the most common gynecological cancer in Europe and Northern America. Yet it receives less attention in the public discourse on cancer than cervical cancer and ovarian cancer. Could this be because the survival rates of endometrial cancer are fairly high (around 80-85%) and higher than for other gynecological cancers? Is it because public research funding is comparatively low for endometrial cancer? Or is it because there are no global policy initiatives for endometrial cancer by the WHO such as those for cervical and breast cancer?
This report provides a general overview of key characteristics of endometrial cancer. It highlights disparities between countries and socioeconomic groups. It also describes the care process and the latest innovations and details many challenges that women with endometrial cancer are facing during their patient journey. A description of current international policy initiatives and recommendations to improve the care for women with endometrial cancer concludes the report.
The five overarching recommendations to improve endometrial cancer care and the outcomes of women are to:
• Raise awareness and increase the visibility of endometrial cancer
• Provide patient-centered support and information
• Ensure optimal care delivery
• Foster research
• Reduce health disparities between socioeconomic groups
IHE will present and discuss the report at the ESMO Congress 2024 in Barcelona and the World Cancer Congress 2024 of the UICC in Geneva.
IHE REPORT 2024:12, IHE: Lund, Sweden
